The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain glioblastoma, epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Not stated	2024-02-28		NCT06283927

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Haaglanden Medical Centre	17
Insel Gruppe AG, University Hospital Bern	224
Jasper Gerritsen	5
Massachusetts General Hospital	758
Technical University of Munich	85
Universitaire Ziekenhuizen KU Leuven	262
University Hospital Heidelberg	109
University of California, San Francisco	637

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Erasmus MC	Rotterdam	Netherlands	2
Inselspital Universitätsspital Bern	Bern	Switzerland	2
Massachusetts General Hospital	Boston	United States	1015
Medical Center Haaglanden	The Hague	Netherlands	2
Technical University Munich	Munich	Germany	4
University Hospital Heidelberg	Heidelberg	Germany	18
University Hospital Leuven	Leuven	Belgium	14
University of California, San Francisco	San Francisco	United States	294